TEVA PHARMACEUTICAL INDUSTRIES LTD

Alpha Score of 64 reflects moderate overall profile with strong momentum, strong value, moderate sentiment. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.

Teva Pharmaceutical Industries Ltd. ADR is an American Depositary Receipt representing shares of the Israel-based pharmaceutical company Teva Pharmaceutical Industries Ltd., founded in 1901 and headquartered in Tel Aviv, Israel. The company develops, manufactures, markets, and distributes a broad portfolio of generic medicines and innovative biopharmaceutical products across the United States, Europe, Israel, and international markets. Its generic offerings span various dosage forms including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, creams, sterile products, hormones, high-potency drugs, and cytotoxics, often combined with medical devices. Teva specializes in key therapeutic areas such as the central nervous system with products like COPAXONE for multiple sclerosis, AJOVY for migraine prevention, and AUSTEDO for movement disorders; respiratory treatments including ProAir RespiClick, QVAR RediHaler, and DuoResp Spiromax; and oncology with biosimilars like Truxima and Herzuma, plus BENDEKA and TREANDA injections. Additionally, it supplies active pharmaceutical ingredients, provides contract manufacturing services, and operates a U.S.-based generic and specialty drug distribution platform through Anda. Teva's diverse operations position it as a leading global player in accessible healthcare solutions, serving patients with both cost-effective generics and specialized therapies.